ClinicalTrials | Financial Buzz

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Bicycle Therapeutics Reports Interim BT8009 Phase I Clinical Trial Results

David Kim04/11/2022

17338

Bicycle Therapeutics Limited plc (NASDAQ: BCYC) reported interim Phase I results from the Phase I/II trial of BT8009, a second generation BTC that targets Nectin-4. Results were presented on...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Protalix BioTherapeutics and Chiese Global Rare Diseases Report Topline Results from the Phase III BALANCE Clinical Trial

David Kim04/04/2022

17383

Protalix BioTherapeutics Inc. (NYSE: PLX) has reported topline results from the BALANCE pivotal Phase III clinical trial evaluating pegunigalsidase alfa (PRX–102), 1 mg/kg, administered every two weeks. “We are pleased...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Data Lock in Tollovir Phase 2 Clinical Trial

financial buzz01/24/202201/26/2022

2514

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized...

Breaking News Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients

financial buzz01/24/202201/26/2022

2746

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease theragnostic joint venture partner NLC Pharma Ltd., today announced a data...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Market Buzz

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2 Clinical Trial Results

financial buzz01/12/202201/26/2022

3332

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Merck (NYSE: MRK) Positive Data in Covid-19 Antiviral Drug Trial

financial buzz10/01/2021

2005

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Merck on the Rise After Revealing Positive Data in Covid-19 Antiviral Drug Trial” Merck (NYSE: MRK) climbed over...

Tag: ClinicalTrials